THE SWARM · FIVE SEATS

Five frontier seats. One rotating judge.

Each model reasons in parallel on the active target. Confidence scores are published with every dossier.

MOST RECENT MISSION

Bicyclic peptides for KRAS G12C inhibition

TARGET
KRAS G12C
MODALITY
Bicyclic peptide
AREA
Non-small cell lung cancer
STATUS
Complete
MODEL 01
DONE
Literature Synthesis
CONFIDENCE
74%
MODEL 02
DONE
Novelty Scout
CONFIDENCE
70%
MODEL 03
DONE
Red Team
CONFIDENCE
76%
MODEL 04
DONE
Patents & Prior Art
CONFIDENCE
65%
MODEL 05
DONE
Adversarial Optimiser
CONFIDENCE
61%